Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2016, Article ID 6158436, 7 pages
http://dx.doi.org/10.1155/2016/6158436
Research Article

Serum Metabolomic Response to Long-Term Supplementation with all-rac-α-Tocopheryl Acetate in a Randomized Controlled Trial

1Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA
2Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Nutritional Epidemiology Branch, Bethesda, MD, USA
3Metabolon, Inc., Durham, NC, USA
4Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
5Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Biostatistics Branch, Bethesda, MD, USA

Received 18 May 2016; Accepted 28 August 2016

Academic Editor: H. K. Biesalski

Copyright © 2016 Alison M. Mondul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Reiter, Q. Jiang, and S. Christen, “Anti-inflammatory properties of α- and γ-tocopherol,” Molecular Aspects of Medicine, vol. 28, no. 5-6, pp. 668–691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. Traber, “Vitamin E inadequacy in humans: causes and consequences,” Advances in Nutrition, vol. 5, no. 5, pp. 503–514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. O. P. Heinonen, D. Albanes, J. Virtamo et al., “Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial,” Journal of the National Cancer Institute, vol. 90, no. 6, pp. 440–446, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. E. A. Klein, I. M. Thopmson Jr., C. M. Tangen et al., “Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT),” The Journal of the American Medical Association, vol. 306, no. 14, pp. 1549–1556, 2009. View at Google Scholar
  5. J. M. Gaziano, R. J. Glynn, W. G. Christen et al., “Vitamins E and C in the prevention of prostate and total cancer in men: the physicians' health study II randomized controlled trial,” The Journal of the American Medical Association, vol. 301, no. 1, pp. 52–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Mondul, S. Rohrmann, A. Menke et al., “Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk,” Cancer Causes and Control, vol. 22, no. 6, pp. 827–836, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Mondul, H. C. Rager, W. Kopp, J. Virtamo, and D. Albanes, “Supplementation with α-tocopherol or β-carotene reduces serum concentrations of vascular endothelial growth factor-D, but not -A or -C, in male smokers,” Journal of Nutrition, vol. 141, no. 11, pp. 2030–2034, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. K. Nicholson and J. C. Lindon, “Systems biology: metabonomics,” Nature, vol. 455, no. 7216, pp. 1054–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Cross, S. Boca, N. D. Freedman et al., “Metabolites of tobacco smoking and colorectal cancer risk,” Carcinogenesis, vol. 35, no. 7, pp. 1516–1522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Mondul, S. C. Moore, S. J. Weinstein, E. D. Karoly, J. N. Sampson, and D. Albanes, “Metabolomic analysis of prostate cancer risk in a prospective cohort: the alpha-tocopherol, beta-carotene cancer prevention (ATBC) study,” International Journal of Cancer, vol. 137, no. 9, pp. 2124–2132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. T. M. O'Connell, “Recent advances in metabolomics in oncology,” Bioanalysis, vol. 4, no. 4, pp. 431–451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. Moore, C. E. Matthews, J. N. Sampson et al., “Human metabolic correlates of body mass index,” Metabolomics, vol. 10, no. 2, pp. 259–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Mondul, J. N. Sampson, S. C. Moore et al., “Metabolomic profile of response to supplementation with β-carotene in the alpha-tocopherol, beta-carotene cancer prevention study,” The American Journal of Clinical Nutrition, vol. 98, no. 2, pp. 488–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. P. Wild, A. Scalbert, and Z. Herceg, “Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk,” Environmental and Molecular Mutagenesis, vol. 54, no. 7, pp. 480–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Scalbert, L. Brennan, O. Fiehn et al., “Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research,” Metabolomics, vol. 5, no. 4, pp. 435–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. H. Johnson, O. Slanař, K. W. Krausz et al., “Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics,” The American Journal of Clinical Nutrition, vol. 96, no. 4, pp. 818–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Wong and J. K. Lodge, “A metabolomic investigation of the effects of vitamin E supplementation in humans,” Nutrition and Metabolism, vol. 9, no. 1, article 110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Cheng, A. Joyce, K. Yates, B. Aouizerat, and A. J. Sanyal, “Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH),” PLoS ONE, vol. 7, no. 9, Article ID e44106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. The ATBC Cancer Prevention Study Group, “The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance,” Annals of Epidemiology, vol. 4, no. 1, pp. 1–10, 1994. View at Publisher · View at Google Scholar
  20. A. M. Evans, C. D. DeHaven, T. Barrett, M. Mitchell, and E. Milgram, “Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems,” Analytical Chemistry, vol. 81, no. 16, pp. 6656–6667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Dehaven, A. M. Evans, H. Dai, and K. A. Lawton, “Organization of GC/MS and LC/MS metabolomics data into chemical libraries,” Journal of Cheminformatics, vol. 2, no. 1, article 9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. N. Sampson, S. M. Boca, X. O. Shu et al., “Metabolomics in epidemiology: sources of variability in metabolite measurements and implications,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 4, pp. 631–640, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Y. Huang and L. J. Appel, “Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans,” The Journal of Nutrition, vol. 133, no. 10, pp. 3137–3140, 2003. View at Google Scholar
  24. G. J. Handelman, L. J. Machlin, K. Fitch, J. J. Weiter, and E. A. Dratz, “Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans,” The Journal of Nutrition, vol. 115, no. 6, pp. 807–813, 1985. View at Google Scholar · View at Scopus
  25. N. Landes, P. Pfluger, D. Kluth et al., “Vitamin E activates gene expression via the pregnane X receptor,” Biochemical Pharmacology, vol. 65, no. 2, pp. 269–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-Y. Cho, D. W. Kang, X. Ma et al., “Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation,” Journal of Lipid Research, vol. 50, no. 5, pp. 924–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Stahl, P. Graf, R. Brigelius-Flohe, W. Wechter, and H. Sies, “Quantification of the α- and γ-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in human serum,” Analytical Biochemistry, vol. 275, no. 2, pp. 254–259, 1999. View at Google Scholar
  28. M. Schultz, M. Leist, M. Petrzika, B. Gassmann, and R. Brigelius-Flohe, “Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?” The American Journal of Clinical Nutrition, vol. 62, no. 6, supplement, pp. 1527S–1534S, 1995. View at Google Scholar
  29. K. M. Lebold, A. Ang, M. G. Traber, and L. Arab, “Urinary α-carboxyethyl hydroxychroman can be used as a predictor of α-tocopherol adequacy, as demonstrated in the Energetics Study,” American Journal of Clinical Nutrition, vol. 96, no. 4, pp. 801–809, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Bruno, S. W. Leonard, J. Li, T. M. Bray, and M. G. Traber, “Lower plasma α-carboxyethyl-hydroxychroman after deuterium-labeled α-tocopherol supplementation suggests decreased vitamin E metabolism in smokers,” The American Journal of Clinical Nutrition, vol. 81, no. 5, pp. 1052–1059, 2005. View at Google Scholar · View at Scopus
  31. K. Hensley, E. J. Benaksas, R. Bolli et al., “New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine,” Free Radical Biology & Medicine, vol. 36, no. 1, pp. 1–15, 2004. View at Publisher · View at Google Scholar · View at Scopus